Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-07-13

FDA Approved: MUCINEX DM MAXIMUM STRENGTH — Supplemental Application (RB Health (US) LLC)

View source ↗

Summary

FDA approved a supplemental application for Mucinex DM Maximum Strength (guaifenesin and dextromethorphan hydrobromide) by RB Health (US) LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mucinex DM Maximum Strength (guaifenesin and dextromethorphan hydrobromide)

Snippet

SUPPL AP for MUCINEX DM MAXIMUM STRENGTH (GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE)